GGrantIndex
← Search

PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF MALARIA THERAPEUTICS

$2,088,140N01FY2018AINIH

Duke University, Durham NC

Investigators

Abstract

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.

View original record on NIH RePORTER →
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF MALARIA THERAPEUTICS · GrantIndex